Myelin Disruption, Neuroinflammation, and Oxidative Stress Induced by Sulfite in the Striatum of Rats Are Mitigated by the pan-PPAR agonist Bezafibrate
Abstract
:1. Introduction
2. Materials and Methods
2.1. Reagents
2.2. Animals
2.3. Sulfite Administration
2.4. Bezafibrate (BEZ) Treatment
2.5. Immunofluorescence Analysis
2.6. Quantitative RT-PCR
2.7. MO3.13 Cell Culture
2.8. Exposure of MO3.13 Cells to Sulfite and BEZ and Viability
2.9. Statistical Analysis
3. Results
3.1. BEZ Post-Treatment Prevents Sulfite-Induced Changes on Myelin Structure in the Striatum and Reduced the Viability of MO3.13 Cells
3.2. BEZ Post-Treatment Prevents Sulfite-Induced Neuroinflammation and Oxidative Stress in the Striatum
3.3. BEZ Pre-Treatment Prevents Sulfite-Induced Alterations on Myelin Structure and Neuroinflammation in the Striatum, and Reduced Viability of MO3.13 Cells
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Claerhout, H.; Witters, P.; Régal, L.; Jansen, K.; Van Hoestenberghe, M.-R.; Breckpot, J.; Vermeersch, P. Isolated Sulfite Oxidase Deficiency. J. Inherit. Metab. Dis. 2018, 41, 101–108. [Google Scholar] [CrossRef] [PubMed]
- Johnson, J.L.; Duran, M. Molybdenum Cofactor Deficiency and Isolated Sulfite Oxidase Deficiency. In The Metabolic and Molecular Bases of Inherited Disease; Valle, D., Antonarakis, S., Ballabio, A., Beaudet, A., Mitchell, G.A., Eds.; McGraw-Hill: New York, NY, USA, 2001; pp. 3181–3217. ISBN 9780071459969. [Google Scholar]
- Atwal, P.S.; Scaglia, F. Molybdenum Cofactor Deficiency. Mol. Genet. Metab. 2016, 117, 1–4. [Google Scholar] [CrossRef] [PubMed]
- Westerlinck, H.; Meylaerts, L.; Van Hoestenberghe, M.R.; Rossi, A. Sulfite Oxidase Deficiency in a Newborn. J. Belg. Soc. Radiol. 2014, 97, 113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Spiegel, R.; Schwahn, B.C.; Squires, L.; Confer, N. Molybdenum Cofactor Deficiency: A Natural History. J. Inherit. Metab. Dis. 2022, 45, 456–469. [Google Scholar] [CrossRef] [PubMed]
- Grings, M.; Moura, A.P.; Parmeggiani, B.; Marcowich, G.F.; Amaral, A.U.; de Souza Wyse, A.T.; Wajner, M.; Leipnitz, G. Disturbance of Brain Energy and Redox Homeostasis Provoked by Sulfite and Thiosulfate: Potential Pathomechanisms Involved in the Neuropathology of Sulfite Oxidase Deficiency. Gene 2013, 531, 191–198. [Google Scholar] [CrossRef] [PubMed]
- Parmeggiani, B.; Moura, A.P.; Grings, M.; Bumbel, A.P.; de Moura Alvorcem, L.; Tauana Pletsch, J.; Fernandes, C.G.; Wyse, A.T.S.; Wajner, M.; Leipnitz, G. In Vitro Evidence That Sulfite Impairs Glutamatergic Neurotransmission and Inhibits Glutathione Metabolism-Related Enzymes in Rat Cerebral Cortex. Int. J. Dev. Neurosci. 2015, 42, 68–75. [Google Scholar] [CrossRef]
- de Moura Alvorcem, L.; da Rosa, M.S.; Glänzel, N.M.; Parmeggiani, B.; Grings, M.; Schmitz, F.; Wyse, A.T.S.; Wajner, M.; Leipnitz, G. Disruption of Energy Transfer and Redox Status by Sulfite in Hippocampus, Striatum, and Cerebellum of Developing Rats. Neurotox. Res. 2017, 32, 264–275. [Google Scholar] [CrossRef]
- Herken, E.N.; Kocamaz, E.; Erel, O.; Celik, H.; Kucukatay, V. Effect of Sulfite Treatment on Total Antioxidant Capacity, Total Oxidant Status, Lipid Hydroperoxide, and Total Free Sulfydryl Groups Contents in Normal and Sulfite Oxidase-Deficient Rat Plasma. Cell Biol. Toxicol. 2009, 25, 355–362. [Google Scholar] [CrossRef]
- Grings, M.; Moura, A.P.; Amaral, A.U.; Parmeggiani, B.; Gasparotto, J.; Moreira, J.C.F.; Gelain, D.P.; Wyse, A.T.S.; Wajner, M.; Leipnitz, G. Sulfite Disrupts Brain Mitochondrial Energy Homeostasis and Induces Mitochondrial Permeability Transition Pore Opening via Thiol Group Modification. Biochim. Biophys. Acta-Mol. Basis Dis. 2014, 1842, 1413–1422. [Google Scholar] [CrossRef] [Green Version]
- Zhang, X.; Vincent, A.S.; Halliwell, B.; Wong, K.P. A Mechanism of Sulfite Neurotoxicity. J. Biol. Chem. 2004, 279, 43035–43045. [Google Scholar] [CrossRef] [Green Version]
- Grings, M.; Moura, A.P.; Parmeggiani, B.; Pletsch, J.T.; Cardoso, G.M.F.; August, P.M.; Matté, C.; Wyse, A.T.S.; Wajner, M.; Leipnitz, G. Bezafibrate Prevents Mitochondrial Dysfunction, Antioxidant System Disturbance, Glial Reactivity and Neuronal Damage Induced by Sulfite Administration in Striatum of Rats: Implications for a Possible Therapeutic Strategy for Sulfite Oxidase Deficiency. Biochim. Biophys. Acta-Mol. Basis Dis. 2017, 1863, 2135–2148. [Google Scholar] [CrossRef] [PubMed]
- Glänzel, N.M.; Grings, M.; da Rosa-Junior, N.T.; Carvalho, L.M.C.; Mohsen, A.; Wipf, P.; Wajner, M.; Vockley, J.; Leipnitz, G. The Mitochondrial-targeted Reactive Species Scavenger JP4-039 Prevents Sulfite-induced Alterations in Antioxidant Defenses, Energy Transfer, and Cell Death Signaling in Striatum of Rats. J. Inherit. Metab. Dis. 2021, 44, 481–491. [Google Scholar] [CrossRef]
- Grings, M.; Seminotti, B.; Karunanidhi, A.; Ghaloul-Gonzalez, L.; Mohsen, A.W.; Wipf, P.; Palmfeldt, J.; Vockley, J.; Leipnitz, G. ETHE1 and MOCS1 Deficiencies: Disruption of Mitochondrial Bioenergetics, Dynamics, Redox Homeostasis and Endoplasmic Reticulum-Mitochondria Crosstalk in Patient Fibroblasts. Sci. Rep. 2019, 9, 12651. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mellis, A.-T.; Roeper, J.; Misko, A.L.; Kohl, J.; Schwarz, G. Sulfite Alters the Mitochondrial Network in Molybdenum Cofactor Deficiency. Front. Genet. 2021, 11, 594828. [Google Scholar] [CrossRef] [PubMed]
- Schwahn, B.C.; Van Spronsen, F.J.; Belaidi, A.A.; Bowhay, S.; Christodoulou, J.; Derks, T.G.; Hennermann, J.B.; Jameson, E.; König, K.; McGregor, T.L.; et al. Efficacy and Safety of Cyclic Pyranopterin Monophosphate Substitution in Severe Molybdenum Cofactor Deficiency Type A: A Prospective Cohort Study. Lancet 2015, 386, 1955–1963. [Google Scholar] [CrossRef] [PubMed]
- Corona, J.C.; Duchen, M.R. PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s. Neurochem. Res. 2015, 40, 308–316. [Google Scholar] [CrossRef] [Green Version]
- Desvergne, B.; Wahli, W. Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism *. Endocr. Rev. 1999, 20, 649–688. [Google Scholar] [CrossRef] [Green Version]
- Liang, H.; Ward, W.F. PGC-1α: A Key Regulator of Energy Metabolism. Adv. Physiol. Educ. 2006, 30, 145–151. [Google Scholar] [CrossRef]
- Johri, A.; Calingasan, N.Y.; Hennessey, T.M.; Sharma, A.; Yang, L.; Wille, E.; Chandra, A.; Beal, M.F. Pharmacologic Activation of Mitochondrial Biogenesis Exerts Widespread Beneficial Effects in a Transgenic Mouse Model of Huntington’s Disease. Hum. Mol. Genet. 2012, 21, 1124–1137. [Google Scholar] [CrossRef] [Green Version]
- Dumont, M.; Stack, C.; Elipenahli, C.; Jainuddin, S.; Gerges, M.; Starkova, N.; Calingasan, N.Y.; Yang, L.; Tampellini, D.; Starkov, A.A.; et al. Bezafibrate Administration Improves Behavioral Deficits and Tau Pathology in P301S Mice. Hum. Mol. Genet. 2012, 21, 5091–5105. [Google Scholar] [CrossRef] [Green Version]
- Seminotti, B.; Grings, M.; Glänzel, N.M.; Vockley, J.; Leipnitz, G. Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as a Potential Therapy for Inherited Metabolic Disorders. Biochem. Pharmacol. 2023, 209, 115433. [Google Scholar] [CrossRef] [PubMed]
- Paxinos, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition; Elsevier: Amsterdam, The Netherlands, 2006; ISBN 9780080475158. [Google Scholar]
- da Rosa-Junior, N.T.; Parmeggiani, B.; Glänzel, N.M.; de Moura Alvorcem, L.; Brondani, M.; Britto, R.; Grings, M.; Ortiz, V.D.; Turck, P.; da Rosa Araujo, A.S.; et al. Antioxidant System Disturbances and Mitochondrial Dysfunction Induced by 3-Methyglutaric Acid in Rat Heart Are Prevented by Bezafibrate. Eur. J. Pharmacol. 2022, 924, 174950. [Google Scholar] [CrossRef] [PubMed]
- Olivera-Bravo, S.; Fernández, A.; Sarlabós, M.N.; Rosillo, J.C.; Casanova, G.; Jiménez, M.; Barbeito, L. Neonatal Astrocyte Damage Is Sufficient to Trigger Progressive Striatal Degeneration in a Rat Model of Glutaric Acidemia-I. PLoS ONE 2011, 6, e20831. [Google Scholar] [CrossRef] [PubMed]
- Olivera-Bravo, S.; Isasi, E.; Fernández, A.; Rosillo, J.C.; Jiménez, M.; Casanova, G.; Sarlabós, M.N.; Barbeito, L. White Matter Injury Induced by Perinatal Exposure to Glutaric Acid. Neurotox. Res. 2014, 25, 381–391. [Google Scholar] [CrossRef]
- Bobermin, L.D.; Roppa, R.H.A.; Gonçalves, C.-A.; Quincozes-Santos, A. Ammonia-Induced Glial-Inflammaging. Mol. Neurobiol. 2020, 57, 3552–3567. [Google Scholar] [CrossRef]
- Livak, K.J.; Schmittgen, T.D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
- Iwata, K.; Café-Mendes, C.C.; Schmitt, A.; Steiner, J.; Manabe, T.; Matsuzaki, H.; Falkai, P.; Turck, C.W.; Martins-de-Souza, D. The Human Oligodendrocyte Proteome. Proteomics 2013, 13, 3548–3553. [Google Scholar] [CrossRef]
- Ribeiro, C.A.J.; Hickmann, F.H.; Wajner, M. Neurochemical Evidence That 3-methylglutaric Acid Inhibits Synaptic Na+, K+-ATPase Activity Probably through Oxidative Damage in Brain Cortex of Young Rats. Int. J. Dev. Neurosci. 2011, 29, 1–7. [Google Scholar] [CrossRef] [Green Version]
- Boggs, J.M. Myelin Basic Protein: A Multifunctional Protein. Cell. Mol. Life Sci. 2006, 63, 1945–1961. [Google Scholar] [CrossRef]
- Polito, A.; Reynolds, R. NG2-Expressing Cells as Oligodendrocyte Progenitors in the Normal and Demyelinated Adult Central Nervous System. J. Anat. 2005, 207, 707–716. [Google Scholar] [CrossRef]
- Steudler, J.; Ecott, T.; Ivan, D.C.; Bouillet, E.; Walthert, S.; Berve, K.; Dick, T.P.; Engelhardt, B.; Locatelli, G. Autoimmune Neuroinflammation Triggers Mitochondrial Oxidation in Oligodendrocytes. Glia 2022, 70, 2045–2061. [Google Scholar] [CrossRef] [PubMed]
- Rodríguez-Pascau, L.; Vilalta, A.; Cerrada, M.; Traver, E.; Forss-Petter, S.; Weinhofer, I.; Bauer, J.; Kemp, S.; Pina, G.; Pascual, S.; et al. The Brain Penetrant PPARγ Agonist Leriglitazone Restores Multiple Altered Pathways in Models of X-Linked Adrenoleukodystrophy. Sci. Transl. Med. 2021, 13, eabc0555. [Google Scholar] [CrossRef] [PubMed]
- Buntinx, M.; Vanderlocht, J.; Hellings, N.; Vandenabeele, F.; Lambrichts, I.; Raus, J.; Ameloot, M.; Stinissen, P.; Steels, P. Characterization of Three Human Oligodendroglial Cell Lines as a Model to Study Oligodendrocyte Injury: Morphology and Oligodendrocyte-Specific Gene Expression. J. Neurocytol. 2003, 32, 25–38. [Google Scholar] [CrossRef] [PubMed]
- Franklin, R.J.M.; Ffrench-Constant, C. Regenerating CNS Myelin—From Mechanisms to Experimental Medicines. Nat. Rev. Neurosci. 2017, 18, 753–769. [Google Scholar] [CrossRef]
- Chen, J.; Wang, F.; Huang, N.; Xiao, L.; Mei, F. Oligodendrocytes and Myelin: Active Players in Neurodegenerative Brains? Dev. Neurobiol. 2022, 82, 160–174. [Google Scholar] [CrossRef]
- Duncan, I.D.; Radcliff, A.B. Inherited and Acquired Disorders of Myelin: The Underlying Myelin Pathology. Exp. Neurol. 2016, 283, 452–475. [Google Scholar] [CrossRef]
- Taib, T.; Leconte, C.; Van Steenwinckel, J.; Cho, A.H.; Palmier, B.; Torsello, E.; Lai Kuen, R.; Onyeomah, S.; Ecomard, K.; Benedetto, C.; et al. Neuroinflammation, Myelin and Behavior: Temporal Patterns Following Mild Traumatic Brain Injury in Mice. PLoS ONE 2017, 12, e0184811. [Google Scholar] [CrossRef] [Green Version]
- Miron, V.E.; Boyd, A.; Zhao, J.-W.; Yuen, T.J.; Ruckh, J.M.; Shadrach, J.L.; van Wijngaarden, P.; Wagers, A.J.; Williams, A.; Franklin, R.J.M.; et al. M2 Microglia and Macrophages Drive Oligodendrocyte Differentiation during CNS Remyelination. Nat. Neurosci. 2013, 16, 1211–1218. [Google Scholar] [CrossRef] [Green Version]
- Traiffort, E.; Kassoussi, A.; Zahaf, A.; Laouarem, Y. Astrocytes and Microglia as Major Players of Myelin Production in Normal and Pathological Conditions. Front. Cell. Neurosci. 2020, 14, 79. [Google Scholar] [CrossRef] [Green Version]
- Hays, T. Role of Peroxisome Proliferator-Activated Receptor-α (PPARα) in Bezafibrate-Induced Hepatocarcinogenesis and Cholestasis. Carcinogenesis 2004, 26, 219–227. [Google Scholar] [CrossRef] [Green Version]
- Topaktas, M.; Kafkas, N.E.; Sadighazadi, S.; Istifli, E.S. In Vitro Cytogenetic Toxicity of Bezafibrate in Human Peripheral Blood Lymphocytes. Cytotechnology 2017, 69, 579–589. [Google Scholar] [CrossRef]
- Wyse, A.T.S.; Grings, M.; Wajner, M.; Leipnitz, G. The Role of Oxidative Stress and Bioenergetic Dysfunction in Sulfite Oxidase Deficiency: Insights from Animal Models. Neurotox. Res. 2019, 35, 484–494. [Google Scholar] [CrossRef] [PubMed]
- Simpson, D.S.A.; Oliver, P.L. ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease. Antioxidants 2020, 9, 743. [Google Scholar] [CrossRef] [PubMed]
- Zhao, Y.; Zhang, J.; Zheng, Y.; Zhang, Y.; Zhang, X.J.; Wang, H.; Du, Y.; Guan, J.; Wang, X.; Fu, J. NAD+ Improves Cognitive Function and Reduces Neuroinflammation by Ameliorating Mitochondrial Damage and Decreasing ROS Production in Chronic Cerebral Hypoperfusion Models through Sirt1/PGC-1α Pathway. J. Neuroinflammation 2021, 18, 207. [Google Scholar] [CrossRef] [PubMed]
- Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine; Oxford University Press: Oxford, UK, 2015; Volume 3, ISBN 9780198717478. [Google Scholar]
- Qin, C.; Zhou, L.-Q.; Ma, X.-T.; Hu, Z.-W.; Yang, S.; Chen, M.; Bosco, D.B.; Wu, L.-J.; Tian, D.-S. Dual Functions of Microglia in Ischemic Stroke. Neurosci. Bull. 2019, 35, 921–933. [Google Scholar] [CrossRef] [PubMed]
- Seminotti, B.; Grings, M.; Tucci, P.; Leipnitz, G.; Saso, L. Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders. Front. Cell. Neurosci. 2021, 15, 488. [Google Scholar] [CrossRef]
- Thorburne, S.K.; Juurlink, B.H.J. Low Glutathione and High Iron Govern the Susceptibility of Oligodendroglial Precursors to Oxidative Stress. J. Neurochem. 2002, 67, 1014–1022. [Google Scholar] [CrossRef]
- Velayutham, M.; Hemann, C.F.; Cardounel, A.J.; Zweier, J.L. Sulfite Oxidase Activity of Cytochrome c: Role of Hydrogen Peroxide. Biochem. Biophys. Rep. 2016, 5, 96–104. [Google Scholar] [CrossRef] [Green Version]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Glänzel, N.M.; Parmeggiani, B.; Grings, M.; Seminotti, B.; Brondani, M.; Bobermin, L.D.; Ribeiro, C.A.J.; Quincozes-Santos, A.; Vockley, J.; Leipnitz, G. Myelin Disruption, Neuroinflammation, and Oxidative Stress Induced by Sulfite in the Striatum of Rats Are Mitigated by the pan-PPAR agonist Bezafibrate. Cells 2023, 12, 1557. https://doi.org/10.3390/cells12121557
Glänzel NM, Parmeggiani B, Grings M, Seminotti B, Brondani M, Bobermin LD, Ribeiro CAJ, Quincozes-Santos A, Vockley J, Leipnitz G. Myelin Disruption, Neuroinflammation, and Oxidative Stress Induced by Sulfite in the Striatum of Rats Are Mitigated by the pan-PPAR agonist Bezafibrate. Cells. 2023; 12(12):1557. https://doi.org/10.3390/cells12121557
Chicago/Turabian StyleGlänzel, Nícolas Manzke, Belisa Parmeggiani, Mateus Grings, Bianca Seminotti, Morgana Brondani, Larissa D. Bobermin, César A. J. Ribeiro, André Quincozes-Santos, Jerry Vockley, and Guilhian Leipnitz. 2023. "Myelin Disruption, Neuroinflammation, and Oxidative Stress Induced by Sulfite in the Striatum of Rats Are Mitigated by the pan-PPAR agonist Bezafibrate" Cells 12, no. 12: 1557. https://doi.org/10.3390/cells12121557